Why Is Everyone Talking About Inovio Stock?
Since reaching an all-time high of $33 per share on June 29, Inovio Pharmaceuticals (NASDAQ: INO) is down nearly 61%, turning an investment of $10,000 at its peak to just $3,933 as of Oct. 8. Many market participants have joined in the discussion about the plunge, from disgruntled investors upset with the share performance to new investors wondering how to buy the dip.
As it turns out, Inovio's headwinds show no sign of subsiding and have arguably gotten worse in the coming weeks. Today, let's look at what's going on behind Inovio and why investors should look for safer coronavirus stocks.
Image source: Getty Images.
Source Fool.com
